Satoh, M. et al. 2011. Clinical Assessment of Bortezomib for Multiple Myeloma in Comparison with Thalidomide. Journal of Pharmacy & Pharmaceutical Sciences. 14, 1 (Feb. 2011), 78–89. DOI:https://doi.org/10.18433/J3VP44.